B&M European Value Retail S.A. Strong Q4 and On-going Performance

B&M European Value Retail S.A.

B&M European Value Retail S.A. (LON: BME), the UK’s leading variety goods value retailer, today announced its Preliminary Results for the 52 weeks to 30 March 2019.

HIGHLIGHTS

● Group revenues1 increased by 17.1% to £3,486.3m (2018: £2,976.3m), 17.0% at constant currency2 for the 52 week comparable period to the previous year

● UK B&M3 store fascia revenue1 growth of 8.7%, including Like-for-Like revenue4 growth of 0.7% for the year, including 5.8% in the fourth quarter, unadjusted for Easter timing (+6.7% after Easter adjustment)

● Group profit before tax increased by 8.7% to £249.4m for the 52 week period (2018: £229.3m), diluted earnings per share 20.5p (2018:18.6p)

● UK B&M store fascia Adjusted EBITDA1&5 growth of 13.5% to £297.0m (2018: £261.7m), with a 45bps increase in margin to 10.6% of revenue

● Important progress clearing out slow-moving inventory in both Germany and France with more work to be done to implement the direct sourcing model in those markets

● Cash generated from operations of £259.4m for the 52 week period (2018: £242.0m), year-end net debt6 of £621.6m and net debt6 to EBITDA of 1.99x, which equates to 1.75x excluding the capital expenditure incurred to date on the Bedford distribution centre (2018: 1.72x)

● Recommended final dividend7 increased to 4.9p per share (FY18: 4.8p) to be paid on 2 August 2019, bringing full year ordinary dividend to 7.6p per share, an increase of 5.7%

● 44 net new B&M UK fascia stores opened in the period (54 gross) and at least a further 50 gross new stores planned for this financial year, benefiting from plentiful availability of attractive new store opportunities

● New 1m sq ft distribution centre under construction in Bedford (to support UK store expansion needs for foreseeable future) on schedule for January 2020 commissioning, with rental and commissioning costs of c.£12m being incurred in FY20 before operational efficiencies are realised in FY21

● Pleasing start to Q1 with mid-single digit Like-for-Like4 in B&M UK fascia stores.

Simon Arora, B&M European Value Retail S.A. Chief Executive, said,

“B&M has again delivered strong results against the challenging backdrop of continued structural change in our industry, rising costs and uncertain times for consumers, demonstrating that its value credentials remain as resonant as ever with customers, whether they need a bargain or just enjoy one.

We have made important progress in establishing platforms for further long term expansion in both Germany and France although there is much work to be done to implement the disruptive, value-led B&M model in these large new markets.

We enter the new financial year with renewed trading momentum particularly in the UK, a high quality new store expansion programme in place, and investing in our new infrastructure to support future growth. I’m confident B&M is well-positioned to deliver further strong progress in the current year and beyond.”

Share on:

Latest Company News

James Cropper: Better materials require better questions

James Cropper says better material choices start with understanding the full requirements of a product, from performance and design to sustainability and end-of-life considerations.

Can nuclear energy play a bigger role in the energy transition?

Nuclear power is being reassessed as countries seek reliable low-carbon electricity, with SMRs, financing, regulation and supply chains likely to determine how quickly new capacity can be deployed.

Why scientific breakthroughs are creating new opportunities

Biotech investment is being driven by medical demand, advances in drug development and pharmaceutical demand for new treatments, but company selection remains critical because clinical and regulatory risks are high.

EDX Medical expands employee health screening with wider disease testing

EDX Medical is expanding employee health screening with tests designed to identify hundreds of diseases from one or two samples, with three major UK employers expected to start programmes later in 2026.

Arbuthnot Commercial ABL provides growth funding to Cross + Morse

Arbuthnot Commercial ABL has provided growth funding to Cross + Morse, supporting the Birmingham manufacturer's expansion and Astwood Group's plans for further acquisitions.

Physitrack expands into AI-powered physical therapy practice management

Physitrack is expanding into AI-powered electronic medical records and practice management, combining clinical documentation, scheduling and patient management with its existing digital rehabilitation technology.

    Search